Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357)

Overview

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is a distinguished biopharmaceutical firm dedicated to the advancement of healthcare through the research, development, production, and sale of innovative pharmaceutical solutions. Established in 2002 and based in Huzhou, China, the company has extended its reach beyond national borders, making significant strides in the international healthcare scene. Specializing in the field of allergic diseases, Wolwo Bio-Pharmaceutical has positioned itself as a leader in offering effective diagnostic and treatment options for a variety of allergic conditions. With a strong commitment to incorporating cutting-edge technologies like stem cell research and medical artificial intelligence, the company continues to push the boundaries of what's possible in biomedicine today.

Products and Services

Changdi (farinae farinae drops): Developed as a therapeutic solution for patients suffering from allergies caused by mites, Changdi is a testament to the company's innovative approach to allergy treatment. Through sublingual administration, it offers a convenient and effective way to manage allergic reactions to farinae farinae, a common household allergen.

Changhao (artemisia annua pollen allergen sublingual drops): Catering to individuals with allergies to artemisia annua pollen, Changhao exemplifies Wolwo Bio-Pharmaceutical's dedication to addressing a wide range of allergen sources. This product employs a sublingual delivery system, allowing for the direct absorption of the allergen extract and promoting a desensitization process.

Changdian (dust mite skin prick diagnostic kits): Recognizing the importance of accurate diagnosis in the effective management of allergic diseases, Changdian offers a reliable skin prick test kit for the identification of dust mite allergies. This diagnostic tool is an essential first step in the allergy treatment process, ensuring targeted and effective therapeutic interventions.

Changdian II (house dust mite skin pricking diagnostic kits): As an enhanced version of its predecessor, Changdian II upgrades the diagnostic process for house dust mite allergies. With improved sensitivity and specificity, this kit facilitates a more precise diagnosis, paving the way for customized treatment plans and improved patient outcomes.

In addition to these products, Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. is deeply invested in the exploration and development of advanced medical technologies such as stem cell therapy and artificial intelligence solutions. These initiatives reflect the company's forward-thinking philosophy and its commitment to leading the biopharmaceutical industry into new frontiers of patient care and treatment efficacy.